Meropenem Rowex (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Rowex, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, ventilator‑associated pneumonia, meningitis, septicemia and febrile neutropenia in hospitalized patients.

GNH USA supplies Meropenem Rowex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious infections that involve resistant Gram‑negative and Gram‑positive bacteria.

- Complicated intra‑abdominal infections: provides rapid bacterial eradication to resolve intra‑abdominal sepsis. - Hospital‑acquired pneumonia: achieves high lung tissue concentrations to treat resistant pneumonia. - Ventilator‑associated pneumonia: eliminates pathogenic organisms causing ventilator‑related lung infection. - Meningitis: penetrates the cerebrospinal fluid to clear bacterial meningitis. - Septicemia: rapidly reduces bloodstream bacterial load in systemic infection. - Febrile neutropenia: offers empiric coverage for high‑risk neutropenic patients.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Injection site phlebitis: redness or pain at the IV site. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or high doses. - Clostridioides difficile‑associated diarrhea: can lead to colitis. - Renal impairment: acute kidney injury in susceptible individuals. - Hepatic failure: rare but potentially life‑threatening liver dysfunction.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for adverse events. - Assess renal function: adjust dosing in renal insufficiency. - Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. - Adjust dose in hepatic impairment: consider reduced exposure. - Use only for confirmed susceptible organisms: avoid unnecessary broad‑spectrum exposure. - Avoid in patients with known carbapenem hypersensitivity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several concomitant medications; awareness helps prevent toxicity.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, heightening toxicity risk. - Concurrent nephrotoxic agents: can exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: watch for additive nephrotoxicity. - NSAIDs: may further impair renal clearance.